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ABSTRACT 
The green bottle fly (Lucilia sericata) larvae are amongst the first colonizers of 
carrion and are well studied for their impact in forensics, decomposition ecology, and 
medicine. The larvae of L. sericata are the only FDA approved species for maggot 
therapy and can be successful in wound debridement, disinfection, and contribute to 
wound healing and tissue regeneration. Because these larvae naturally colonize habitats 
with high microbial loads, it is not surprising that they have a large repertoire of 
antimicrobial peptides. In this study, 2nd instar L. sericata larvae were exposed to Gram-
negative bacteria (Pseudomonas aeruginosa or Acinetobacter baumannii) and evaluated 
for differences in transcript abundance due to bacterial exposure identified through 
RNA-seq analysis. Differentially expressed genes were identified and characterized by 
analyzing RNA-seq data with traditional software analysis and gene ontology 
methodologies. Up-regulated and down-regulated genes included those associated with 
the recognition, signaling cascades, and effector molecule transcription of the insect 
immune response pathways. Differentially expressed transcripts also included some 
previously identified antimicrobial peptides. Other differentially expressed genes were 
uncharacterized and so functions were not attributed to these genes. The data produced 
in this study may contribute to future studies such as the potential identification of new 
antimicrobial peptides, genome editing or genetic engineering of Medical Maggots™, 
and transcriptome studies in L. sericata as well as other organisms. 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
As a high-energy source, carrion provides essential resources to a large variety of 
species including plants, insects, vertebrates, and microbes (Parmenter and MacMahon 
2009, Barton et al. 2013). In some instances, successional patterns in the presence of 
these organisms during the decomposition of carrion allows for the determination of 
forensically relevant information such as the postmortem interval (PMI) and can provide 
insight about factors surrounding the death and subsequent treatment of the remains 
(Anderson and VanLaerhoven 1996, Anderson et al. 2000, Boehme et al. 2014). 
Examination of the types of insect species present and even differences in geographic 
populations of the same insect species can help determine if remains have been moved 
from the original site of death to another location (Byrne et al. 1995, Anderson et al. 
2000). 
Blow flies, such as Lucilia sericata (Meigen) (Diptera: Calliphoridae), are 
amongst the first arthropods to colonize remains (Anderson et al. 2000). They locate 
remains via attraction to the volatile organic compounds (VOCs) produced by 
decomposing remains and bacteria (Anderson et al. 2000, Frederickx et al. 2012). The 
decomposition process produces a variety of VOCs, which include hydrocarbons, 
aldehydes, ketones, alcohols, esters, aromatics and sulfides (Statheropoulos et al. 2005). 
For example, L. sericata is preferentially attracted to the VOCs dimethyl disulfide 
(DMDS) and butan-1-ol (Frederickx et al. 2012).  
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Some of the VOCs are quorum-sensing compounds that can serve as attraction 
and oviposition cues to the colonizing insects and also signify the resource quality of the 
remains (Ma et al. 2012, Tomberlin et al. 2012, Liu et al. 2016). L. sericata showed 
increased attraction and oviposition when exposed to the wild type bacteria Proteus 
mirabilis with the ability to swarm as opposed to a non-swarming strain of the bacteria 
(Ma et al. 2012). The ability of arthropods to exhibit behavioral changes in response to 
compounds associated with microbial activity and behavior is a proposed mechanism 
arthropods use to evaluate the quality of the carrion resource (Tomberlin et al. 2012). 
Volatile organic compounds produced by wound-isolated bacteria differentially 
attract female screwworms Cochliomyia hominivorax (Coquerel) (Diptera: 
Calliphoridae) for oviposition depending on the incubation time of the bacteria and also 
the amount and type of bacterial species present (Chaudhury et al. 2010). A complex 
relationship between stimulus and response is indicated by volatiles from substrates with 
more bacterial species present and volatiles from 48 and 72 h incubation times resulting 
in significantly more attraction and oviposition of the female screwworm (Chaudhury et 
al. 2010). 
 
Interactions Between Microbes and Insects 
 
In many instances, bacteria and fly larvae compete for carrion-associated 
resources. Mechanisms such as nutrient alteration and production of antibiotics and 
toxins are highlighted as factors in the coevolution and coexistence of microbes, 
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vertebrates, and rich food sources (Janzen 1977). Some arthropods associated with 
carrion produce antibiotics, exhibit antimicrobial strategies or evolve to be successful in 
the presence of microbes (Rozen et al. 2008, Cazander et al. 2009a, Cerovsky et al. 
2010, Diaz-Roa et al. 2014). Microbes, with strategies of their own, can also become 
successful at the expense of other colonizing organisms by producing VOCs that deter 
colonization and repel other organisms (Janzen 1977, Deron et al. 2006, Andersen et al. 
2010a).  
Physical and biochemical interactions between microbes and insects are of 
interest to the forensic and medical fields. In the case of forensics, microbial 
communities in carrion can affect the response of colonizing blow flies (Peleg et al. 
2008, Tomberlin et al. 2012), which could in turn impact the PMI determination. 
Identifying these biochemical markers produced by microbes and insects alike could 
lead to the discovery of novel antimicrobial compounds (Cerovsky et al. 2010).  
 
Metagenomic Analysis 
 
Metagenomic examination of the relationships between bacteria associated with 
wounds on human hosts is of particular importance due to the prevalence of multi drug 
resistant bacterial strains. Improved sequencing and gene expression analysis methods 
(Shendure and Ji 2008) combined with more powerful data analysis tools allow a more 
in-depth examination of the biochemical interactions between bacteria and blow flies 
like L. sericata. The gene expression response of L. sericata to a variety of factors can 
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be evaluated with the aid of the previously assembled transcriptome for this species (Sze 
et al. 2012). Gene expression analysis has been examined in L. sericata for the 
antimicrobial compound lucifensin (Valachova et al. 2013), as well as temporal gene 
expression analysis in the development of forensically relevant blow flies (Tarone and 
Foran 2011, Boehme et al. 2014). The availability of large data sets for comparative 
studies, as well as the use of RNA-sequencing technology and data analysis tools will 
support and aid gene expression studies in L. sericata.  
 
Medical and Economic Threat of Drug Resistant Pathogens 
 
The decreasing investment in antibacterial drug development coupled with the 
increase in antimicrobial resistance could lead to a future medical and socio-economic 
catastrophe (Chopra et al. 2008, Boucher et al. 2009, Lawrence and Jeyakumar 2013). 
Demographic trends in developed countries combined with advancements in medical 
care lead to a growing number of elderly patients and patients undergoing surgery, 
transplantation, chemotherapy, and neonatal intensive care (Chopra et al. 2008, Boucher 
et al. 2009). These demographic and patient trends produce an even greater number of 
vulnerable and immunocompromised individuals at risk of nosocomial infections 
(Chopra et al. 2008). The health care costs for patients with antibiotic-resistant 
nosocomial infections are substantial (Wilson et al. 2004, Chopra et al. 2008). Wilson et 
al. (2004) reported that the hospital cost for treating a patient with severe burns was on 
average $98,575 higher if they acquired a multi-drug resistant Acinetobacter baumannii 
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infection as compared to control patients. Resistance to first-line agents often results in 
administration of less satisfactory and sometimes toxic drugs, with an associated 
increase in the length of hospital stay and other complications (Chopra et al. 2008).  
Drug resistant bacteria threaten public safety, and concern has been expressed for 
over 20 years (Harrison and Lederberg 1998, Wise et al. 1998, Livermore 2003, Beovic 
2006, Talbot et al. 2006). Despite the overwhelming amount of knowledge and concern, 
there still has not been an adequate response to this threat (Livermore 2003, Boucher et 
al. 2009, Lawrence and Jeyakumar 2013). This limitation is due to drug development 
being difficult, costly, and time consuming; however, new antimicrobials are needed to 
treat infections caused by ESKAPE (Enterococcus faecium, Staphylococcus aureus, 
Klebsiella pneumoniae, A. baumannii, Pseudomonas aeruginosa, Enterobacter spp.) 
pathogens that currently cause the majority of hospital infections and effectively 
“escape” the effects of antibacterial drugs (Talbot et al. 2006, Boucher et al. 2009, 
Lawrence and Jeyakumar 2013).  Additionally, panantibiotic-resistant infections now 
occur and several highly resistant Gram-negative bacteria, including Acinetobacter and 
Pseudomonas species, are emerging as significant pathogens in both the United States 
and other parts of the world (Chopra et al. 2008, Boucher et al. 2009).  
Bacteria can become drug resistant from target site modifications or from 
functional bypassing of that target (Livermore 2003). Resistance can be contingent on 
impermeability, efflux, or enzymatic inactivation. If resistance is not inherent, then it 
may arise due to biofilm formation, mutation, or DNA transfer by plasmids, transposons 
and lysogenic bacteriophage (Davies et al. 1998, Livermore 2003, Beovic 2006, 
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Birkenhauer et al. 2014). As summarized by Livermore (2003), antibacterial 
agents may actually cause the emergence of variants with an increased propensity to 
develop further resistance. These hypermutators have up to 200-fold higher mutation 
rate than normal cells and so are more likely to become resistant to a first encounter with 
an antibacterial drug. Once selected by this first drug, they are then “primed” to develop 
resistance to subsequent antibacterial agents (Livermore 2003). In an effort to combat 
multi-drug resistant pathogens, there is a great need to provide funding for new research, 
develop alternative antibiotic approaches, as well as provide monetary incentives for 
drug companies to pursue antibiotic drug development (Boucher et al. 2009, Lawrence 
and Jeyakumar 2013). 
 
Maggot Debridement Therapy and Success of L. sericata 
 
Maggot debridement therapy (MDT), a drug alternative approach, is essentially a 
controlled and therapeutic maggot infestation of a wound that aids in debridement, 
disinfection, and cleaning (Sherman 2014). Live fly larvae, typically disinfected L. 
sericata, are applied to wounds with a special dressing and help remove dead and 
infected tissue and debris, stimulating new growth and healthy tissue formation (Baer 
1931, Sherman 2014). Baer (1931) began extensive clinical research with MDT after 
marveling at the condition of wounds in two soldiers that had sustained compound 
fractures of the femur. The soldiers lay wounded for seven days with no food or water 
and their wounds were heavily infested with maggots. The wounds and the health of the 
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soldiers were in excellent condition with evidence of new tissue growth and no signs of 
infection. Baer (1931) also focused his efforts on rearing sterile maggots so they could 
be applied to wounds without causing detrimental effects to the patient. Blow fly larvae 
were applied and deemed successful in healing wounds in patients with chronic 
osteomyelitis (Baer 1931). Although the beneficial effects of maggots in wounds has 
been reported since the 16th century (Goldstein 1931), it was Baer (1931) that developed 
the proper methods to study the application of blow fly larvae to wounds in a clinical 
setting (ScienceNews 1931, Sherman et al. 2000). 
Lucilia sericata larvae successfully debride, disinfect, and stimulate growth of 
new tissue and healing in wounds (Baer 1931, Nigam et al. 2006, Sherman 2014). The 
digestive enzymes that the larvae secrete and excrete, as well as the physical and 
scraping movement of the larvae across the wound, contribute to the debridement of 
necrotic tissue (Chambers et al. 2003, Sherman 2014). Larvae disinfect wounds in part 
by physically moving across the wound and disrupting biofilm formation and also by 
ingesting microbes (Mumcuoglu et al. 2001, Sherman 2014). Larvae secrete 
antimicrobial compounds that inhibit the growth of bacteria (Daeschlein et al. 2007, 
Bexfield et al. 2008, Cazander et al. 2009b, Cerovsky et al. 2010, Teh et al. 2013) and 
disrupt the formation of biofilms (Cazander et al. 2009a, Cazander et al. 2010, Bohova et 
al. 2014). MDT stimulates new tissue growth and wound healing in clinical settings 
(Baer 1931, Mumcuoglu et al. 1998, Nigam et al. 2006). Larvae also produce 
compounds that decrease the generation of pro-inflammatory factors and have a 
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beneficial effect on wound healing by regulating the inflammatory response (van der 
Plas et al. 2009, Cazander et al. 2012). 
 
Objectives and Hypothesis 
 
To analyze gene expression of medical-grade L. sericata 2nd instar exposed to 
Pseudomonas aeruginosa and Acinetobacter baumannii bacteria (test group) and those 
larvae not exposed (control group).  
H0: No difference detected in the level of gene expression between the test and 
control group larvae. 
H1: Differential gene expression occurs between test and control group larvae. 
Rationale/Justification:  
There is an urgent need to discover new mechanisms to overcome antibiotic 
resistant pathogens. Specifically, A. baumannii and P. aeruginosa are amongst the most 
challenging and resistant pathogens encountered in the hospital, battlefield, and natural 
disaster setting (Maragakis and Perl 2008, Peleg et al. 2008, Mihu and Martinez 2011, 
O'Shea 2012, Biswal et al. 2014). Acinetobacter, Enterobacter species, and P. 
aeruginosa were identified most frequently from infections associated with combat 
acquired type III open tibia fractures in a group of soldiers serving in Iraq and 
Afghanistan (Johnson et al. 2007).  
 Treatment of infected wounds with L. sericata larvae can be successful (Sherman 
2002, Cazander et al. 2013).  Antimicrobial activity by the larvae is one of the
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 mechanisms by which L. sericata controls wound pathogens (Daeschlein et al. 2007, 
Cazander et al. 2009b, Cerovsky et al. 2010, Bohova et al. 2014). Lucifensin is an 
example of a well-characterized antibacterial substance that is found in the 
excretions/secretions of these larvae (Andersen et al. 2010b, Cerovsky et al. 2010, 
Valachova et al. 2013, Valachova et al. 2014).  
 There is justification for further examination of the biochemical interactions that 
are taking place between the bacterial pathogens and the larvae. Exposing larvae to the 
chosen strains of bacteria and examining genes that are differentially expressed can 
potentially lead to the discovery of novel antimicrobial products. Gene expression 
analysis has progressed with improvements in sequencing technology, as well as data 
analysis methods and technology. Also, with decreased sequencing costs, more genomic 
and transcriptomic sequencing data is becoming available for non-model organisms.  
This project will also contribute to the growing amount of sequencing data that is 
available for this medically and forensically important species, L. sericata.  
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CHAPTER II 
RESEARCH, RESULTS, AND DISCUSSION 
 
Introduction 
 
 Without policies to stop the spread of antimicrobial resistance, there could be 10 
million deaths globally annually by 2050 (O'Neill 2016). The economic cost of 
antimicrobial resistance will also continue to grow and could become an estimated 100 
trillion USD by the year 2050 (O'Neill 2016). At least two million people in the US 
become infected with antibiotic resistant bacteria annually, and at least 23,000 people 
die each year as a direct result (Centers for Disease Control and Prevention 2017). Based 
on 2014 data for acute care hospitals, approximately one in 25 U.S. patients will contract 
at least one infection during the course of their hospital stay (Centers for Disease Control 
and Prevention 2016).  
Antibiotics represent 4.5% of the global pharmaceutical market and is expected 
to have a 2% increase in compound annual growth rate (CAGR) by 2020 (Newswire 
2016). Main drivers for the increase in CAGR are an aging population, rise in infectious 
diseases, increased prevalence of hospital-acquired infections, and new drug launches 
(Newswire 2016).  While there are incentives for pharmaceutical companies to develop 
antibiotics, most newly developed compounds are lacking in biological innovation and 
public health benefit (Doshi 2015) as they are extensions to already existing drug classes 
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(Deak et al. 2016). Thus, emphasis should be placed on the development of novel 
compounds and innovative methods to overcome microbial infections. 
New antimicrobials are needed to treat infections caused by ESKAPE (E. 
faecium, S. aureus, K. pneumoniae, A. baumannii, P. aeruginosa, Enterobacter spp.) 
pathogens that currently cause the majority of hospital infections and effectively 
“escape” the effects of antibacterial drugs (Talbot et al. 2006, Boucher et al. 2009, 
Lawrence and Jeyakumar 2013). Highly resistant Gram-negative pathogens are 
emerging as significant pathogens in both the US and other parts of the world (Chopra et 
al. 2008, Boucher et al. 2009). 
 As a potential source of novel antibiotics, L. sericata larvae have drawn attention 
due to their successful use in wound therapy as medical maggots. These larvae 
successfully debride, disinfect, and stimulate growth of new tissue and healing in 
wounds (Baer 1931, Nigam et al. 2006, Sherman 2014). The digestive enzymes the 
larvae secrete and excrete, as well as their physical and scraping movement across the 
wound, contribute to the debridement of necrotic tissue (Chambers et al. 2003, Sherman 
2014). Larvae also secrete antimicrobial compounds (Daeschlein et al. 2007, Bexfield et 
al. 2008, Cazander et al. 2009b, Cerovsky et al. 2010, Teh et al. 2013), disrupt the 
formation of biofilms (Cazander et al. 2009a, Cazander et al. 2010, Bohova et al. 2014), 
and produce anti-inflammatory factors that have a beneficial effect on wound healing by 
regulating the inflammatory response (van der Plas et al. 2009, Cazander et al. 2012). 
 The insect innate immune system has remarkable plasticity due in part to the 
unique selection pressures of different ecological niches (Vilcinskas 2013). A diverse 
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repertoire of antimicrobial peptides is expected for insects that prosper in contaminated 
environments. The transcriptome of L. sericata contains 47 genes that encode putative 
antimicrobial peptides and small proteins, which is the second largest number of these 
peptides reported thus far in a multicellular organism (Pöppel et al. 2015). Analysis of 
the transcriptome with high throughput RNA sequencing (RNA-Seq) provides a 
mechanism to examine and discover genes. The gene expression response of L. sericata 
can be evaluated with the aid of the previously assembled transcriptome (Sze et al. 2012) 
and with the published genome for a closely related species, Lucilia cuprina 
(Wiedemann) (Diptera: Calliphoridae) (Anstead et al. 2015). The gene expression in L. 
sericata for the antimicrobial compound lucifensin (Valachova et al. 2013) has been 
examined along with temporal gene expression in the development of forensically 
relevant blow flies (Tarone and Foran 2011, Boehme et al. 2014).  In this study, 
differential expression analysis was conducted on the transcripts from medical-grade L. 
sericata larvae exposed to A. baumannii and P. aeruginosa to potentially identify genes 
that encode beneficial peptides in response to harmful pathogens.  
 
Materials and Methods 
 
Acquisition and Preparation of Bacteria 
The bacterial strains used were Pseudomonas aeruginosa (Schroeter) Migula 
(ATCC® 15692™; American Type Culture Collection, Manassas, Virginia) isolated 
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from an infected wound and Acinetobacter baumannii Bouvet and Grimont (ATCC® 
19606™) isolated from urine.  
The bacteria were prepared and stored at -80°C according to manufacturer’s 
instructions. The bacteria were cultured on Trypticase Soy Agar (TSA) 24 h in advance 
and single colonies were isolated and passaged onto new TSA plates incubated 18-24 h 
at 37°C. The inoculum was brought to a 0.7 OD600nm in phosphate buffered saline and 
placed on ice until use. The inoculum was enumerated by a tenfold serial dilution in PBS 
spread onto TSA plates and incubated 18-24 h at 37°C.  
Arrival and Preparation of Medical Maggots 
MedicalMaggots™ L. sericata larvae were supplied by Monarch Labs (Irvine, 
CA).  Disinfected eggs were impregnated in sterile gauze and shipped overnight. Upon 
arrival, larvae were examined and verified to be second instar, an approximate count was 
performed, and a small collection of larvae was placed in Trypticase Soy Broth (TSB) 
and incubated at 37°C overnight and monitored for bacterial growth. Larvae were 
aseptically removed from the shipping vial and 15 larvae were aliquoted into each 
treatment tube.  
Exposure tubes consisted of 10 µL of bacterial inoculum added onto a slant of 
2 mL of TSA in 5 mL round bottom polypropylene tubes (Thermo Fisher Scientific Inc., 
Wilmington, Delaware), see Fig. 1. Eight replicate treatment tubes were prepared for 
each bacterial concentration and control tubes were prepared by adding 10 µL PBS. The 
tubes were incubated at room temperature for 30 minutes in the biosafety hood prior to 
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use.  Larvae (15) were then aseptically added to each tube, which was capped and 
incubated at room temperature in the biosafety hood.  
Collection of Larvae After Exposure Time Points 
 A summary of samples collected for the experiment is provided in Table 1. 
 
Table 1 List of Sample Names 
 
 
 
After 1 and 4 h, larvae from 4 control tubes and 8 treatment tubes (4 tubes for P. 
aeruginosa and 4 for A. baumannii) were sterilely collected.  Ten larvae from each 
collection were placed into a 1.5 mL microcentrifuge tube (Thermo Fisher Scientific
2nd 1st 2nd 2nd
Treatment Exposure 
(h)
Replicate Experiment 1 
Sample 
Identifier
Experiment 2 
Sample 
Identifier
Experiment 3 
Sample 
Identifier
Experiment 4 
Sample 
Identifier
PBS (control) 1 A C1A1 C1A2 C1A3 C1A4
B C1B1 C1B2 C1B3 C1B4
C C1C1 C1C2 C1C3 C1C4
D C1D1 C1D2 C1D3 C1D4
P. aeruginosa 1 A PA1A1 PA1A2 PA1A3 PA1A4
B PA1B1 PA1B2 PA1B3 PA1B4
C PA1C1 PA1C2 PA1C3 PA1C4
D PA1D1 PA1D2 PA1D3 PA1D4
A. baumannii 1 A AB1A1 AB1A2 AB1A3 AB1A4
B AB1B1 AB1B2 AB1B3 AB1B4
C AB1C1 AB1C2 AB1C3 AB1C4
D AB1D1 AB1D2 AB1D3 AB1D4
PBS (control) 4 A C4A1 C4A2 C4A3 C4A4
B C4B1 C4B2 C4B3 C4B4
C C4C1 C4C2 C4C3 C4C4
D C4D1 C4D2 C4D3 C4D4
P. aeruginosa 4 A PA4A1 PA4A2 PA4A3 PA4A4
B PA4B1 PA4B2 PA4B3 PA4B4
C PA4C1 PA4C2 PA4C3 PA4C4
D PA4D1 PA4D2 PA4D3 PA4D4
A. baumannii 4 A AB4A1 AB4A2 AB4A3 AB4A4
B AB4B1 AB4B2 AB4B3 AB4B4
C AB4C1 AB4C2 AB4C3 AB4C4
D AB4D1 AB4D2 AB4D3 AB4D4
ble 1. Sample Identifiers 
Larval Stage Used:
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 Inc., Wilmington, Delaware) and immediately placed in an isopronol/dry ice mixture to 
flash freeze the larvae, then stored at -80°C for subsequent RNA analysis.  The 
remaining 5 larvae were collected and externally sterilized by serial immersion in 1 mL 
of ethanol followed by SporGon (Decon Laboratories Inc., Sussex, UK) (Crippen and 
Sheffield 2006). The tube was gently shaken for 3 min, then the ethanol or Sporgon 
drained using a sterile barrier screen. Larvae were then transferred aseptically to a new 
tube containing sterile H2O and left for 1 min, drained, and transferred to a 14 mL 
centrifuge tube containing 1.5 mL sterile PBS.  The larvae were then homogenized using 
a sonicator-model 8851-34 (Cole Parmer, Vernon Hills, IL).  The homogenate was 
serially diluted by a 10 fold dilution to 10-6 in PBS and plated onto TSA plates; 
incubated 18-24 hr at 37°C, and enumerated. Remaining homogenate volume was stored 
at -20°C. The experiment was repeated on four separate days.  The larvae in experiment 
2 were identified as being first instar and the total number of larvae was limited, so only 
the bacterial exposure portion of the experiment was carried out and no RNA analysis 
was done. For this group, approximately 15 larvae per sample were collected. 
RNA Extraction and Sequencing 
 For RNA extraction, five larvae were removed from each 1.5 mL 
microcentrifuge tube and placed in a new 1.5 mL microcentrifuge tube. All tubes and 
consumables were RNAse-free. RNA was extracted in a two-step process. First, whole 
RNA was extracted using TriReagent (Sigma-Aldrich Corp., St. Louis, Missouri) 
preparation according to manufacturer’s protocols. Briefly, one sample (~5 whole 
larvae) was macerated in 1 mL of cold TriReagent. Following this, 50 mL of ice-cold 
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BAN reagent (Molecular Research Center, Inc., Cincinnati, Ohio) was added and the 
solution was vigorously mixed. Next, the tubes were centrifuged at 14,000 G at 4°C for 
15 minutes to isolate the RNA from the DNA and proteins. Approximately 500 µL of the 
top clear layer was carefully removed with a pipet and added to 500 µL of ice-cold 100% 
isopropanol. The tubes were mixed via inversion three times and allowed to rest on ice 
for 10 min to precipitate the RNA. The precipitate was then centrifuged at 14,000 G at 
4°C for 15 min. Next, the supernatant was completely removed, 1 mL of ice-cold 70% 
ethanol was used to wash the RNA pellet, and the pellet was centrifuged at 4°C for 5 
min at 14,000 G. The ethanol was eluted, and any remaining ethanol was allowed to 
completely evaporate. The RNA was then dissolved in a 10µL mixture of 99 µL of 
DNase/RNase/Nucleotide-free water and 1 µL of SUPERase•In™ (Invitrogen, Life 
Technologies Incorporated, Grand Island, New York).  
For the second step, the extracted RNA was further purified using a Qiagen 
RNeasy Micro Kit and on-column DNase treatment following manufacturer protocols 
(Qiagen Inc., Valencia, California). RNA was eluted again into a fresh 1:100µL mixture 
of SUPERase•In and DNase/RNase/Nucleotide-free water and stored at -80°C until 
sequencing.  
Sample concentration and quality was assessed with NanoDrop (Thermo Fisher 
Scientific Inc., Wilmington, Delaware) and an Agilent 2100 BioAnalyzer (Agilent 
Technologies Inc., Santa Clara, California). In total, 72 paired-end libraries were 
multiplexed and sequenced on six separate RNA HiSeq flow cells. RNA was sequenced 
on an Illumina Hi-Seq 2500 (Illumina, Inc., San Diego, California) following 
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manufacturer protocols regarding library preparation. All sequencing was performed by 
the Genomics and Bioinformatics Services at Texas A&M AgriLife Research (College 
Station, TX). Sequence cluster identification, quality prefiltering, base calling and 
uncertainty assessment were done in real time using Illumina's HCS 2.2.68 and RTA 
1.18.66.3 software with default parameter settings. Sequencer.bcl basecall files were 
demultiplexed and formatted into .fastq files using bcl2fastq 2.17.1.14 script 
configureBclToFastq.pl. 
Data Analysis 
 Sequencing data was downloaded from the Texas Agrilife Research website 
https://download.txgen.tamu.edu with project specific credentials. The sequencing files, 
reference genomes, and applicable programs were uploaded to the Texas A&M Institute 
for Genome Sciences and Society (TIGSS) HPC Cluster. The HPC cluster provides 
computational resources and systems administration support to allow data analysis and 
storage solutions for large data sets. 
The sequencing reads were first aligned to the published L. cuprina reference 
genome (Anstead et al. 2015) which includes a transcriptome for which there are 14,452 
annotated genes.  For alignment, the program TopHat v2.1.1  (Trapnell et al. 2009) was 
used to map reads to the genome. Sequence alignment to the L. sericata genome was 
also performed to see if it would improve the alignment rate. No further analysis was 
performed due to the lack of a compatible annotation file. Mapped reads from the L. 
cuprina alignment output files were provided as input to the Cufflinks application 
(Trapnell et al. 2010) (http://cufflinks.cbcb.umd.edu/) which uses this map against the 
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genome to assemble the reads into transcripts (Trapnell et al. 2012). Cuffdiff (v2.2.1), a 
part of the Cufflinks package, takes the aligned reads from two or more conditions and 
reports genes and transcripts that are differentially expressed using a rigorous statistical 
analysis (Trapnell et al. 2012). Differential expression analysis was performed using the 
TopHat default settings and also with an increased mismatch rate and read-edit distance 
setting. Replicates within each day were treated as technical replicates and the four 
replicates (A-D) were added together for the Cuffdiff analysis. Each of the three 
experimental days (1, 3, and 4) were defined as biological replicates. Therefore, samples 
AB1A1-AB1D1, AB1A3-AB1D3, and AB1A4-AB1D4 would be incorporated as input 
into the analysis and the Cuffdiff output sample name would be AB1. Larvae exposed to 
A. baumannii for 1 h represent the AB1 group and C1 is the corresponding control 
group. Larvae exposed to A. baumannii for 4 h represent the AB4 group and C4 is the 
corresponding control group. Larvae exposed to P. aeruginosa for 1 h represent the PA1 
group and C1 is the corresponding control group. Lastly, larvae exposed to P. 
aeruginosa for 4 h represent the PA4 group and C4 is the corresponding control group.  
Since longer transcripts are more likely to have reads mapped to them, correction 
for transcript length bias is carried out in Cuffdiff with the use of normalized FPKM 
(fragments per kilobase of transcript per one million mapped reads) values (Trapnell et 
al. 2012). Cuffdiff output expression data files were indexed and visualized using R 
v3.2.4 (R Core Team 2016) and the CummeRbund v2.12.1 
(http://compbio.mit.edu/cummeRbund/) package to facilitate exploration of genes 
identified by Cuffdiff as differentially expressed (Trapnell et al. 2012). The cut-off for 
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determining significant differential expression was an adjusted P value (Q value) ≤  0.05 
from the Cuffdiff output. Genes from each type of analysis that were differentially 
expressed at a significant level were compared using an online tool (Oliveros 2007-
2015) in order to determine if any identified genes were represented in more than one 
analysis set. Differential expression analysis was also explored with the DESeq2 v1.10.1 
(Love et al. 2014) and Bioconductor v3.2 software packages (Gentleman et al. 2004).   
Gene Ontology 
The functional roles of differentially expressed protein products were identified 
by various methods. First, differentially expressed genes with L. cuprina gene names 
were researched in the Ensembl Metazoa database (Kersey et al. 2016) and also with the 
use of the InterPro (Finn et al. 2016) and the UniProt (The UniProt Consortium 2014) 
databases. The BioMart portion of Ensembl (Kinsella et al. 2011) was used to assign 
alternative gene names to the identified L. cuprina significant differentially expressed 
genes. Another method involved comparing identified genes to those found in 
Drosophila melanogaster Meigen (Diptera: Drosophilidae) data in 
http://www.flybase.org (Gelbart and Emmert 2010). The nodes of the transcriptome 
were also compared against characterized proteins from other organisms using a 
translated Basic Local Alignment Search Tool (BLAST) search (Altschul et al. 1990). 
After assigning functions and characterizing protein products of differentially expressed 
genes, some gene sets were further analyzed using the Panther database and gene 
enrichment software tools (Thomas et al. 2006, Mi et al. 2016).  
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Results 
Bacteria Exposure to L. sericata Larvae 
Larvae (Medical Maggots™) that arrived from Monarch Labs did not produce 
bacterial growth when enriched overnight in TSB at 37°C. The starting inoculum 
concentrations for A. baumanni for the three biological experimental replicates ranged 
from 3.1 to 6.6 x 109 CFU/mL and for P. aeruginosa ranged from 0.5 to 1.5 x 1010 
CFU/mL. 
Larvae exposed to A. baumanni or P. aeruginosa had direct contact with the 
bacteria on the surface of the exposure tube where they typically either remained or 
burrowed slightly into the agar (Fig. 1). 
Fig. 1: Larvae just below surface of agar in 5 mL round bottom tube.
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Only live larvae were collected during the experiment. Larvae that were exposed 
to PBS did not produce bacterial growth and larvae exposed to A. baumannii or P. 
aeruginosa produced bacterial colonies phenotypically similar to the respective species. 
Three larvae each were individually enriched overnight in TSB at 37°C after 
exposure to either A. baumannii and P. aeruginosa and external disinfection . Larvae 
showed no signs of bacterial growth with the exception of one larva post P. aeruginosa 
exposure. 
Cuffdiff Analysis with Default TopHat Parameters 
Several genes were differentially expressed post A. baumannii or P. aeruginosa 
treatment of L. sericata larvae. Alignment of sequencing reads to the L. cuprina 
reference genome resulted in a 31.0% concordant pair alignment rate when default 
parameters were selected. Output diagnostics for a typical alignment using default 
TopHat parameters, which includes a mismatch rate setting of two, can be seen in Fig. 2. 
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Fig. 2: Example summary of TopHat alignment output with default parameters. 
Table 2 presents a summary of Cuffdiff outputs with default TopHat parameters 
for AB1 compared to C1. A total of seven genes displayed significant differential 
expression (Q ≤  0.05) compared to the control when L sericata larvae were exposed to 
A. baumannii for 1 h. All seven of the identified genes (100%) were expressed at a lower 
level in the larvae exposed to A. baumannii as compared to the control (ie, no 
differentially expressed genes were upregulated). Gene FF38_12536, which is associated 
with an integral component of the plasma membrane, displayed the greatest fold change 
for a decrease in gene expression between C1 and AB1. 
Table 3 presents a summary of Cuffdiff outputs with default TopHat parameters 
for PA1 compared to C1. A total of eight genes displayed significant differential 
expression (Q ≤  0.05) compared to the control when L sericata larvae were exposed to 
P aeruginosa for 1 h. Two of the eight differentially expressed genes (25%) were 
expressed at a higher level in the larvae exposed to P. aeruginosa as compared to the 
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control (ie, upregulated). Relative expression levels of the eight differentially expressed 
genes for PA1 vs C1 can be visualized in Fig. 3. Gene FF38_02709, which is an 
uncharacterized protein, had the greatest fold change in terms of increased gene 
expression between C1 and PA1. Gene FF38_12536, which is associated with an 
integral component of the plasma membrane, displayed the greatest fold change for a 
decrease in gene expression between C1 and PA1.
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Table 2 Summary of Cuffdiff Output with Default TopHat Parameters (AB1 vs C1) 
Gene V1 (AB1) V2 (C1) Change1 Q value EL Gene Description 
FF38_02450 9.1927 18.8507 1.03606 0.03753 Down GO:0042302; structural constituent of cuticle2 
FF38_14459! 1.3011 13.4536 3.37018 0.03753 Down Protein coding3 
FF38_14465 0.5321 7.79236 3.87236 0.03753 Down Protein coding3 
FF38_12518 2.9482 6.75891 1.19698 0.03753 Down GO:0016021; integral component of plasma membrane
2; 
Dmel/Osiris2 4 
FF38_12536 0.4469 7.24213 4.01832 0.03753 Down Dmel/Osiris15: inferred, integral component of plasma membrane4 
FF38_07366 0.497 1.22405 1.30034 0.03753 Down GO:0004867; serine-type endopeptidase inhibitor activity2 
FF38_00565 3.6553 7.99212 1.12857 0.03753 Down Protein coding3 
Abbreviations: AB1 = larvae exposed to A. baumannii for 1 h, C1 = control group larvae not exposed to bacteria for 1 h, EL = expression level, GO = Gene ontology 
GO term, V1 = Value 1, V2 = Value 2. 
Note: Significant values defined as Q ≤ 0.05. 
1 Change presented as log 2 (fold change) function. 
Source: 2 InterPro, 3 EnsemblMetazoa, 4 FlyBase 
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Table 3 Summary Table of Cuffdiff Output with Default TopHat Parameters (PA1 vs C1) 
Gene V1 (PA1) V2 (C1) Change1 Q value EL Gene Description 
FF38_02450 9.32128 19.3163 1.05122 0.033613 Down GO:0042302; structural constituent of cuticle2 
FF38_05420! 4.79796 2.3866 -1.00746 0.033613 Up GO:0016021; integral component of membrane2 
FF38_14465 1.20161 7.99001 2.73324 0.033613 Down Protein coding3 
FF38_12536 0.3606 7.42597 4.36412 0.033613 Down Dmel/Osiris15; inferred: integral component of plasma membrane4 
FF38_02709 6.24286 2.25863 -1.46676 0.033613 Up Protein coding3 
FF38_03319 2.11099 13.7192 2.7002 0.033613 Down Protein coding3 
FF38_03322 0 1.06204 inf 0.033613 Down Protein coding3 
FF38_03381 13.0863 31.9503 1.28777 0.033613 Down GO:0006030; chitin metabolic process, chitin binding
2; 
Dmel/Peritrophin-15a/15b 4  
Abbreviations: PA1 = larvae exposed to P. aeruginosa for 1 h, C1 = control group larvae not exposed to bacteria for 1 h, EL = expression level, GO = Gene ontology 
GO term, V1 = Value 1, V2 = Value 2. 
Note: Significant values defined as Q ≤ 0.05. 
1 Change presented as log 2 (fold change) function. 
Source: 2 InterPro, 3 EnsemblMetazoa, 4 FlyBase.  
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Fig. 3: Heatmap displaying relative expression levels of genes that are differentially expressed between 
larvae exposed to P. aeuruginosa for one hour (PA1) and control group larvae (C1). Expression levels 
between samples are compared in terms of log10 normalized mapped read (FPKM) values. Light beige 
coloring corresponds to lower levels of gene expression and dark orange coloring corresponds to higher 
levels of gene expression. 
 
Table 4 presents a summary of Cuffdiff outputs with default TopHat parameters 
for AB4 compared to C4. A total of 28 genes displayed significant differential 
expression (Q ≤ 0.05) compared to the control when L sericata larvae were exposed to 
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A. baumannii for 4 h. Twenty-one of the 28 differentially expressed genes (75%) were 
expressed at a higher level in the larvae exposed to A. baumannii as compared to the 
control (ie, upregulated). Genes FF38_02624 (uncharacterized protein) and FF38_01452 
(peptidoglycan catabolic process) had the greatest fold change in terms of increased gene 
expression between C4 and AB4. Gene FF38_02709 (uncharacterized protein) displayed 
the greatest fold change in terms of decreased gene expression between C4 and AB4. 
Table 5 presents a summary of Cuffdiff outputs with default TopHat parameters 
for PA4 compared to C4. A total of 13 genes displayed significant differential 
expression (Q ≤ 0.05) compared to the control when L sericata larvae were exposed to 
P. aeruginosa for 4 h. Six of the 13 differentially expressed genes (46%) were expressed 
at a higher level in the larvae exposed to P. aeruginosa as compared to the control (ie, 
upregulated). Gene FF38_01452 (peptidoglycan catabolic process) had the greatest fold 
change for an increase in gene expression between C4 and PA4. Gene FF38_14459 
(uncharacterized protein) displayed the greatest fold change for a decrease in gene 
expression between C4 and PA4.  
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Table 4 Continued Summary Table of Cuffdiff Output with Default TopHat Parameters (AB4 vs C4) 
Gene V1 (AB4) V2 (C4) Change1 Q value EL Gene Description 
FF38_00033 8.47366 12.3061 0.538313 0.0495804 Down Protein coding3 
FF38_02450 5.57209 3.46503 -0.685352 0.0115688 Up GO:0042302: structural constituent of cuticle2 
FF38_14459 4.80544 12.4898 1.37801 0.0115688 Down Protein coding3 
FF38_06989 30.697 18.8271 -0.705286 0.0115688 Up Protein coding3 
FF38_02624 773.001 299.65 -1.36719 0.0115688 Up Protein coding3 
FF38_02631 142.179 58.1401 -1.29011 0.0115688 Up Protein coding3 
FF38_10586 0.83048 0.34891 -1.25109 0.0115688 Up GO:0035556: Intracellular signal transduction, GO:0046872: 
metal ion binding, GO:0005622: Intracellular3; Protein kinase C-
like, phorbol ester/diacylglycerol-binding domain2 
FF38_02709 4.69109 14.6275 1.64068 0.0115688 Down Protein coding3 
FF38_01452 89.3129 35.0482 -1.34953 0.0115688 Up GO:0009253; peptidoglycan catabolic process (The chemical 
reactions and pathways resulting in the breakdown of 
peptidoglycans, any of a class of glycoconjugates found in 
bacterial cell walls), GO:0045087: innate immune response 
(Innate immune responses are defense responses mediated by 
germline encoded components that directly recognize 
components of potential pathogens)2 
FF38_05096 1047.33 706.448 -0.568068 0.0115688 Up GO:0042302: structural component of cuticle2 
FF38_01073 2.97552 1.60363 -0.891802 0.0115688 Up GO:0005515: Interacting selectively and non-covalently with 
any Protein or protein complex (a complex of two or more 
proteins that may include other non-protein molecules)2; 
Dmel/ecd, ecdysoneless4 
FF38_03041 1.70961 0.936789 -0.867868 0.0115688 Up GO:0005515; protein binding, Immunoglobulin-like domain2 
  29 
Table 4 Continued Summary Table of Cuffdiff Output with Default TopHat Parameters (AB4 vs C4) 
Gene V1 (AB4) V2 (C4) Change1 Q value EL Gene Description 
FF38_02640 2.19129 0.987594 -1.14979 0.0115688 Up GO:0055114; oxidation-reduction process, TauD/TfdA-like 
domain2 
FF38_12829 1.61703 0.815601 -0.987408 0.0115688 Up GO:0035556: Intracellular signal transduction, GO:0046872: 
metal ion binding, GO:0005622: Intracellular; Protein kinase C-
like, phorbol ester/diacylglycerol-binding domain2 
FF38_02573 7.95852 5.30632 -0.584787 0.0320365 Up protein coding3 
FF38_07683 19.8311 28.6538 0.530962 0.0411333 Down GO:0005509; calcium ion binding2 
FF38_11848 12.115 5.10028 -1.24815 0.0115688 Up Protein coding3 
FF38_07690 4.48309 9.78556 1.12616 0.0115688 Down Protein coding3 
FF38_08124 16.9543 10.7624 -0.655655 0.0115688 Up GO:0005576; extracellular region; transferrin like domain; 
Transferrins are a family of eukaryotic iron-binding 
glycoproteins that share the common function of controlling the 
level of free iron in biological fluids2 
FF38_00377 2.23884 1.0181 -1.13687 0.0115688 Up GO:004866; endopeptidase inhibitor activity2 
FF38_05499 396.123 199.958 -0.986249 0.0115688 Up Protein coding3 
FF38_06625 1.24106 0 NA 0.0115688 Up Protein coding3 
FF38_14311 1.65819 2.86966 0.791275 0.0115688 Down Protein coding3 
FF38_14361 4.05522 2.21992 -0.869273 0.0115688 Up GO:0006355: DNA-binding protein D-ETS-6 2 ;GO:0003700: 
transcription factor activity, sequence-specific DNA binding2 
FF38_00565 6.25318 3.94127 -0.665929 0.0115688 Up Protein coding 
FF38_02608 0.817969 0.500276 -0.709321 0.0320365 Up Dmel/Tet: Contains 1 CXXC-type zinc finger; Oxygenase 
domain4 
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Table 4 Continued Summary Table of Cuffdiff Output with Default TopHat Parameters (AB4 vs C4) 
Gene V1 (AB4) V2 (C4) Change1 Q value EL Gene Description 
FF38_03845 1.8576 1.05353 -0.818214 0.0115688 Up GO:0007264: Rad and Gem related GTP binding protein 1; small 
GTPase mediated signal transduction2 
FF38_04564 0.785602 0.443066 -0.826277 0.0115688 Up GO:0034729: Histone-lysine N-methyltransferase, regulation of 
cell cycle2 
Abbreviations: AB4 = larvae exposed to A. baumannii for 4 h, C4 = control group larvae not exposed to bacteria for 4 h, EL = expression level, GO = Gene ontology 
GO term, V1 = Value 1, V2 = Value 2. 
Note: Significant values defined as Q ≤ 0.05. 
1 Change presented as log 2 (fold change) function. 
Source: 2 InterPro via EnsemblMetazoa, 3 EnsemblMetazoa, 4 FlyBase.  
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Table 5 Continued Summary Table of Cuffdiff Output with Default TopHat Parameters (PA4 vs C4) 
Gene V1 (PA4) V2 (C4) Change1 Q value EL Gene Description 
FF38_00033 7.50382 11.8137 0.654766 0.02719 Down Protein coding3 
FF38_14459 1.04258 12.0098 3.52598 0.02719 Down Protein coding3 
FF38_14466 0.470596 1.39336 1.56601 0.0418308 Down Protein coding3 
FF38_02624 73.6322 287.843 1.96687 0.02719 Down Protein coding3 
FF38_02631 15.1156 55.8479 1.88546 0.02719 Down Protein coding3 
FF38_02709 5.98234 14.0707 1.23391 0.02719 Down Protein coding3 
FF38_06525 8.58407 5.08942 -0.754161 0.0418308 Up GO:0055114: oxidation-reduction process, GO:0016491: 
oxidoreductase activity3; TauD/TfdA-like domain2 
FF38_06814 2.46444 4.48856 0.864991 0.0418308 Down GO:0004252; serine-type endopeptidase activity2 
FF38_01452 80.3626 33.63 -1.25677 0.02719 Up GO:0008745: N-acetylmuramoyl-L-alanine amidase activity: 
Proteins containing this domain include zinc amidases that have 
N-acetylmuramoyl-L-alanine amidase activity EC:3.5.1.28. This 
enzyme domain cleaves the amide bond between N-
acetylmuramoyl and L-amino acids in bacterial cell walls 
(preferentially: D-lactyl-L-Ala), GO:0008270: zinc ion binding, 
Peptidoglycan-recognition protein SB1 5 
FF38_09514 7.19281 3.0444 -1.2404 0.02719 Up GO:0005515: Kazal domain, serine proteinase inhibitors2 
FF38_09769 2.5054 1.24238 -1.01194 0.02719 Up GO:0005759; mitochondrial matrix, mitochondrial 
glycoprotein2 
FF38_00377 2.3255 0.978874 -1.24834 0.02719 Up GO:0004866; endopeptidase inhibitor activity, Alpha-2-
macroglobulin, N-terminal2 
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Table 5 Continued Summary Table of Cuffdiff Output with Default TopHat Parameters (PA4 vs C4) 
Gene V1 (PA4) V2 (C4) Change1 Q value EL Gene Description 
FF38_07809 29.8294 17.8153 -0.743617 0.02719 Up Dmel\Lst: Limostatin (Lst) is a peptide hormone produced by 
endocrine corpora cardiaca cells during starvation. Lst 
suppresses insulin production and secretion from insulin-
producing cells by signaling through the G-protein coupled 
receptor PK1-R4 
Abbreviations: PA4 = larvae exposed to P. aeruginosa for 4 h, C4 = control group larvae not exposed to bacteria for 4 h, EL = expression level, GO = Gene ontology 
GO term, V1 = Value 1, V2 = Value 2. 
Note: Significant values defined as Q ≤ 0.05. 
1 Change presented as log 2 (fold change) function. 
Source: 2 InterPro via EnsemblMetazoa, 3 EnsemblMetazoa, 4 FlyBase, 5 INSDC.  
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Pairwise comparisons of expression levels for all genes from Cuffdiff output is 
presented in Fig. 4 (AB4 vs C4) as well as in Fig. 5 (PA4 vs C4).  
Fig. 4: Scatterplot of pairwise gene expression levels between AB4 and C4 with log10 transformed fpkm 
values. Genes that are differentially expressed at a significant level are highlighted and labeled. A data 
point above y=x represents a gene that is expressed at higher level in AB4 than in C4. 
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Fig. 5: Scatterplot of pairwise gene expression levels between PA4 and C4 with log10 transformed fpkm 
values. Genes that are differentially expressed at a significant level are highlighted and labeled. A data 
point above y=x represents a gene that is expressed at higher level in PA4 than in C4. 
 
Six down-regulated differentially expressed genes were common to more than 
one analysis set; the Venn diagram in Fig. 6 presents the down-regulated significant 
differentially expressed genes as they appear in each Cuffdiff analysis performed with 
default TopHat parameters. The down-regulated genes FF38_02450, FF38_14465, and 
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FF38_12536 have similar patterns of expression in both AB1 vs C1 and PA1 vs C1. 
Gene FF38_02450 is associated with cuticle structure, gene FF38_14465 is protein 
coding (no identified function), and FF38_12536 is associated with an integral 
component of the plasma membrane. Genes FF38_00033 and FF38_02709, which are 
both uncharacterized proteins, were down-regulated in both AB4 vs C4 and PA4 vs C4. 
Gene FF38_14459 (uncharacterized protein) was found to be down-regulated in AB1 vs 
C1, AB4 vs C4, and PA4 vs C4. No down-regulated genes were represented in all four 
of the analysis sets.
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Fig. 6: Four-way Venn diagram displaying overlapping counts of significant differentially expressed 
genes that are down-regulated. 
 
 The up-regulated genes displaying significant differential expression from all 
Cuffdiff analysis sets are presented in the Venn diagram in Fig. 7. Gene FF38_00377 
(endopeptidase inhibitor activity) and gene FF38_01452 (peptidoglycan catabolic 
37 
process) were found to be up-regulated in both AB4 vs C4 and PA4 vs C4. Expression 
levels displayed in barplot format for gene FF38_01452 can be examined in Fig. 8. 
Fig. 7: Four-way Venn diagram displaying overlapping counts of significant differentially expressed 
genes that are up-regulated. 
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Fig. 8: Barplot displaying expression level fpkm values for gene FF38_01452 (AB4 vs C4). Gene 
FF38_01452 is associated with a peptidoglycan catabolic process (the chemical reactions and pathways 
resulting in the breakdown of peptidoglycans, any of a class of glycoconjugates found in bacterial cell 
walls). FF38_01452 is also up-regulated in PA4 vs C4. 
 
Cuffdiff Analysis with Adjusted TopHat Parameters 
 Aligning sequencing reads to the L. cuprina reference genome using an increased 
mismatch rate setting in TopHat resulted in an improved alignment rate as compared to 
using the default settings. In one example, the alignment of sequencing reads to the L. 
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cuprina reference genome resulted in a 48.2.% concordant pair alignment rate when the 
mismatch and read-edit distance settings were increased to four. Additional TopHat 
alignment output information from one of the data analysis sets can be seen in Fig. 9.  
Fig. 9: Example summary of TopHat alignment output with increased mismatch rate and read edit distance 
parameters. 
Analysis of the increased mismatch rate alignment data in Cuffdiff resulted in the 
identification of several genes that were differentially expressed after larvae were 
exposed to bacteria.  
Table 6 presents a summary of Cuffdiff outputs with adjusted TopHat parameters 
for AB1 compared to C1. A total of 23 genes displayed significant differential 
expression (Q ≤ 0.05) compared to the control when L sericata larvae were exposed to 
A.baumannii for 1 h. Five of the 23 differentially expressed genes (22%) were expressed 
at a higher level in the larvae exposed to A. baumannii as compared to the control (ie, 
upregulated). Relative expression levels of the 23 differentially expressed genes for AB1 
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vs C1 are displayed in Fig. 10. Gene FF38_08822 (Dmel/edin: defense response to gram 
negative bacterium) had the greatest fold change for increased gene expression between 
C1 and AB1. Gene FF38_14463 (uncharacterized protein) had the greatest fold change 
in terms of decreased gene expression between C1 and AB1. 
Table 7 presents a summary of Cuffdiff outputs with adjusted TopHat parameters 
for PA1 compared to C1. A total of 20 genes displayed significant differential 
expression (Q ≤ 0.05) compared to the control when L sericata larvae were exposed to 
P. aeruginosa for 1 h. Four of the 20 differentially expressed genes (20%) were 
expressed at a higher level in the larvae exposed to P. aeruginosa as compared to the 
control (i.e., upregulated). Gene FF38_02709 (uncharacterized protein) had the greatest 
fold change in terms of increased gene expression between C1 and PA1. Gene 
FF38_14463 (uncharacterized protein) displayed the greatest fold change for a decrease 
in gene expression between C1 and PA1. 
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Table 6 Continued Summary Table of Cuffdiff Output with Adjusted TopHat Parameters (AB1 vs C1) 
Gene V1 (AB1) V2 (C1) Change
1 
Q value EL Gene Description 
FF38_08822 4.02319 0.447964 -3.16689 0.01888 Up Dmel/edin: defense response to gram negative bacterium4 
FF38_09276 4.69492 1.7115 -1.45584 0.01888 Up GO:0005549: odorant binding protein2 
FF38_01916 8.27152 3.73245 -1.14803 0.01888 Up Dmel/Tweedle (various letters e.g P,N,O,B…): structural 
constituent of chitin based cuticle4 
FF38_04326 4.35223 1.59031 -1.45244 0.01888 Up Dmel/pirk Poor Imd response upon knock-in is a negative 
regulator of the Immune Deficiency (Imd) pathway, acting at the 
level of PGRP-LC. Being regulated by the Imd pathway itself, it 
establishes a negative feedback loop adjusting Imd pathway 
activity to the severity of infection4 
FF38_09383 2.3459 0.501464 -2.22593 0.01888 Up Attacin-A, GO:0005576: extracellular region, Attacin_N and 
Attacin_C (antimicrobial peptides)2 
FF38_02450 21.5458 43.8889 1.02645 0.01888 Down GO:0042302: structural constituent of cuticle2 
FF38_06150 9.01248 17.127 0.92627
9 
0.0492522 Down GO:0008152: metabolic process, catalytic/alkaline phosphatase 
activity2 
FF38_14459 3.07672 32.4358 3.39812 0.01888 Down Protein coding3 
FF38_14463 0.311916 7.31653 4.55193 0.01888 Down Protein coding3 
FF38_14461 0 0.642927 inf 0.01888 Down Protein coding3 
FF38_14458 1.15995 8.00718 2.78724 0.01888 Down Protein coding3 
FF38_14465 0.583781 8.58746 3.87873 0.01888 Down Protein coding3 
FF38_04943 1.31274 3.65499 1.47729 0.01888 Down GO:0006810: intracellular transport2 
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Table 6 Continued Summary Table of Cuffdiff Output with Adjusted TopHat Parameters (AB1 vs C1) 
Gene V1 (AB1) V2 (C1) Change
1 
Q value EL Gene Description 
FF38_12518 3.15021 7.64388 1.27886 0.01888 Down GO:0016021: integral component of plasma membrane2; also, 
Dmel/Osiris2 4 
FF38_12526 0.328513 0.986172 1.58589 0.0359619 Down GO:0016021: integral component of plasma membrane2, also 
Dmel/Osiris94 
FF38_12536 0.381483 5.9404 3.96087 0.01888 Down Dmel/Osiris15: inferred integral component of plasma 
membrane4 
FF38_06986 0.0782144 0.547015 2.80607 0.01888 Down Protein coding3 
FF38_02323 0.413629 1.58955 1.94221 0.01888 Down Dmel/Spt7: contributes to histone acetyltransferase activity, 
SAGA complex4 
FF38_02738 5.60945 19.152 1.77156 0.01888 Down Protein coding3 
FF38_02650 16.1981 38.8724 1.26293 0.01888 Down GO:0004867: serine-type endopeptidase inhibitor activity2 
FF38_03322 1.75844 4.66705 1.40821 0.0492522 Down Protein coding3 
FF38_07366 0.879774 1.77354 1.01143 0.01888 Down GO:0004867: serine-type endopeptidase inhibitor activity2 
FF38_00565 2.63618 5.77256 1.13076 0.01888 Down Protein coding3 
Abbreviations: PA4 = larvae exposed to A. baumannii for 1 h, C1 = control group larvae not exposed to bacteria for 1 h, EL = expression level, GO = Gene ontology 
GO term, V1 = Value 1, V2 = Value 2. 
Note: Significant values defined as Q ≤ 0.05. 
1 Change presented as log 2 (fold change) function. 
Source: 2 InterPro via EnsemblMetazoa, 3 EnsemblMetazoa, 4 FlyBase. 
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Table 7 Continued Summary Table of Cuffdiff Output with Adjusted TopHat Parameters (PA1 vs C1) 
Gene V1 (PA1) V2 (C1) Change1 Q value EL Gene Description 
FF38_02709 7.20823 2.45667 -1.55294 0.0294115 Up Protein coding3 
FF38_01916 9.66887 3.83516 -1.33406 0.0294115 Up Dmel/Tweedle: structural constituent of chitin based cuticle4 
FF38_05420 6.6478 3.1884 -1.06004 0.038235 Up GO 0016021: integral component of membrane2 
FF38_01455 45.357 22.4764 -1.01292 0.038235 Up Protein coding3 
FF38_02450 22.8271 44.9909 0.978885 0.0294115 Down GO:0042302: structural constituent of cuticle2 
FF38_10331 24.5678 53.989 1.1359 0.038235 Down Dmel/Gnmt: FBgn0038074 
4; GO:0017174: Glycine N-
Methyltransferase activity2 
FF38_12518 3.52907 7.8344 1.15053 0.038235 Down GO:0016021: integral component of membrane2 
FF38_03845 1.18485 2.74636 1.21281 0.0294115 Down GO:0007264: Rad and Gem related GTP binding protein 1, small GTPase mediated signal transduction2 
FF38_03381 30.8557 72.7032 1.23648 0.0294115 Down GO:0006030: chitin metabolic process, chitin binding
2, also 
Dmel/Peritrophin-15a/15b4 
FF38_02650 15.5385 39.8184 1.35759 0.0294115 Down GO:0004867: serine-type endopeptidase inhibitor activity
2; 
PTHR10083:SF192: immune system process5 
FF38_02738 7.39233 19.6362 1.40942 0.0294115 Down Protein coding 
FF38_04943 1.37335 3.7474 1.44819 0.038235 Down PTHR23324: transfer/carrier protein transporter5 
FF38_04030 3.78797 11.4848 1.60023 0.0294115 Down PTHR22762: glucosidase5 
FF38_12526 0.319991 1.01039 1.6588 0.038235 Down Protein coding3 
FF38_03322 1.37683 4.78086 1.79592 0.038235 Down Protein coding3 
FF38_06986 0.0944128 0.560499 2.56966 0.0294115 Down PTHR11559: hydrolase, esterase5; lipase in Dmel4  
FF38_14465 1.38616 8.78805 2.66445 0.0294115 Down Protein coding3 
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Table 7 Continued Summary Table of Cuffdiff Output with Adjusted TopHat Parameters (PA1 vs C1) 
Gene V1 (PA1) V2 (C1) Change1 Q value EL Gene Description 
FF38_03319 1.64816 11.8379 2.84448 0.0294115 Down Protein coding3 
FF38_12536 0.302546 6.07935 4.32869 0.0294115 Down Dmel/Osiris15: inferred: integral component of plasma membrane4 
FF38_14463 0.223132 7.48631 5.06829 0.0294115 Down Protein coding3 
Abbreviations: PA1 = larvae exposed to P. aeruginosa for 1 h, C1 = control group larvae not exposed to bacteria for 1 h, EL = expression level, GO = Gene ontology 
GO term, V1 = Value 1, V2 = Value 2. 
Note: Significant values defined as Q ≤ 0.05. 
1 Change presented as log 2 (fold change) function. 
Source: 2 InterPro via EnsemblMetazoa, 3 EnsemblMetazoa, 4 FlyBase,5 Panther GO Terms 
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Fig. 10: Heatmap displaying relative expression levels of genes that are differentially expressed between 
larvae exposed to A. baumannii for one hour (AB1) and control group larvae (C1). Expression levels 
between samples are compared in terms of normalized mapped read (FPKM) values. Light blue coloring 
corresponds to lower levels of gene expression and black coloring corresponds to higher levels of gene 
expression. 
 
Pairwise comparisons of expression levels for all genes from Cuffdiff output is 
presented in Fig. 11 (AB1 vs C1) as well as in Fig. 12 (PA1 vs C1). 
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Fig. 11: Scatterplot of pairwise gene expression levels between AB1 and C1 with log10 transformed 
FPKM values. Genes that are differentially expressed at a significant level are highlighted and labeled. A 
data point above y=x represents a gene that is expressed at higher level in AB1 than in C1. 
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Fig. 12: Scatterplot of pairwise gene expression levels between PA1 and C1 with log10 transformed 
FPKM values. Genes that are differentially expressed at a significant level are highlighted and labeled. A 
data point above y=x represents a gene that is expressed at higher level in PA1 than in C1. 
 
Table 8 presents a summary of Cuffdiff outputs with adjusted TopHat parameters 
for AB4 compared to C4. A total of 55 genes displayed significant differential 
expression (Q ≤  0.05) compared to the control when L. sericata larvae were exposed to 
A. baumannii for 4 h. Thirty-nine of the 55 differentially expressed genes (71%) were 
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expressed at a higher level in the larvae exposed to A. baumannii as compared to the 
control (i.e., upregulated). Gene FF38_00375 (endopeptidase inhibitor activity) had the 
greatest fold change for increased gene expression between C4 and AB4. Gene 
FF38_14458 (uncharacterized protein) had the greatest fold change in terms of decreased 
gene expression between C4 and AB4. 
Table 9 presents a summary of Cuffdiff outputs with adjusted TopHat parameters 
for PA4 compared to C4. A total of 21 genes displayed significant differential 
expression (Q ≤ 0.05) compared to the control when L sericata larvae were exposed to P 
aeruginosa for 4 h. Eleven of the 21 differentially expressed genes (52%) were 
expressed at a higher level in the larvae exposed to P. aeruginosa as compared to the 
control (ie, upregulated). Gene FF38_05988 (Dmel\Hsp22: Heat shock protein) had the 
greatest fold change for increased gene expression between C4 and PA4. Genes 
FF38_14459 and FF38_00716 (uncharacterized proteins) had the greatest fold changes 
in terms of decreased gene expression between C4 and PA4. 
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Table 8 Continued Summary Table of Cuffdiff Output with Adjusted TopHat Parameters (AB4 vs C4) 
Gene V1 (AB4) V2 (C4) Change1 Q value EL Gene Description 
FF38_00041 1.54674 0.776243 -0.994649 0.0495804 Up Zinc finger protein-related (PTHR22979)5 
FF38_00375 1.08192 0.136901 -2.98239 0.0115688 Up GO:0004866; endopeptidase inhibitor activity, Alpha-2-
macroglobulin2, also Dmel/Tep1 + 2: Thioester-containing 
protein 1 + 2 4 
FF38_00565 4.46969 2.7702 -0.690183 0.0115688 Up Protein coding3 
FF38_01073 8.12816 4.42301 -0.8779 0.0115688 Up GO:0005515: Interacting selectively and non-covalently with 
any protein or protein complex (a complex of two or more 
proteins that may include other non-protein molecules)2; 
Dmel/ecd ecdysoneless4 
FF38_01326 6.27991 4.16833 -0.591274 0.0115688 Up GO:0019752: carboxylic acid metabolic process, GO:0006520: 
cellular amino acid metabolic process2 
FF38_01452 113.376 48.0906 -1.23729 0.0115688 Up GO:0008745: N-acetylmuramoyl-L-alanine amidase activity -
proteins containing this domain include zinc amidases that have 
N-acetylmuramoyl-L-alanine amidase activity EC:3.5.1.28. This 
enzyme domain cleaves the amide bond between N-
acetylmuramoyl and L-amino acids in bacterial cell walls 
(preferentially: D-lactyl-L-Ala)2, GO:0008270; zinc ion 
binding, Peptidoglycan-recognition protein SB12 
FF38_01558 1.0339 0.56844 -0.863014 0.0115688 Up GO:0005515: protein binding, Immunoglobulin-like domain2 
FF38_02341 0.593508 0.353284 -0.74844 0.0115688 Up Cytokine receptor3, Ig-like domain and FN3 domain2 
FF38_02450 12.6222 8.30891 -0.603233 0.031092 Up GO:0042302: structural constituent of cuticle2 
FF38_02573 15.1712 10.166 -0.577592 0.0114309 Up Protein coding3 
FF38_02624 563.525 215.177 -1.38895 0.031092 Up Protein coding3 
FF38_02631 103.538 41.3612 -1.32381 0.0114309 Up Protein coding3 
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Table 8 Continued Summary Table of Cuffdiff Output with Adjusted TopHat Parameters (AB4 vs C4) 
Gene V1 (AB4) V2 (C4) Change1 Q value EL Gene Description 
FF38_02640 7.17193 3.52667 -1.02405 0.0253467 Up GO:0055114: oxidation-reduction process, TauD/TfdA-like 
domain2 
FF38_02650 15.4517 8.54324 -0.854912 0.0114309 Up GO:0004867: serine-type endopeptidase inhibitor activity2 
FF38_03041 3.1772 1.77464 -0.84023 0.0114309 Up GO:0005515: protein binding, Immunoglobulin-like domain2 
FF38_03845 2.2137 1.14499 -0.951129 0.0114309 Up GO:0007264: Rad and Gem related GTP binding protein 1; 
small GTPase mediated signal transduction2 
FF38_04236 0.835452 0.249738 -1.74214 0.0114309 Up GO:0006508: proteolysis, Cathepsin L2 
FF38_04326 5.63907 3.24967 -0.795163 0.0114309 Up Dmel/pirk Poor Imd response upon knock-in is a negative 
regulator of the Immune Deficiency (Imd) pathway, acting at 
the level of PGRP-LC. Being regulated by the Imd pathway 
itself, it establishes a negative feedback loop adjusting Imd 
pathway activity to the severity of infection4 
FF38_04937 0.441045 0.209709 -1.07254 0.0114309 Up GO:0004252: serine-type endopeptidase activity, Serine 
protease easter2 
FF38_04966 7.2273 4.54245 -0.669987 0.0114309 Up GO:0006508: proteolysis, serine protease snake, Peptidase S1A, 
chymotrypsin family2 
FF38_05096 1333.82 905.746 -0.558391 0.0114309 Up GO:0042302: structural constituent of cuticle2 
FF38_05499 523.276 248.648 -1.07347 0.0381029 Up Protein coding3 
FF38_06150 3.26257 1.66263 -0.972545 0.0114309 Up GO:0008152: metabolic process, catalytic/alkaline phosphatase 
activity2 
FF38_06209 0.396645 0.158991 -1.3189 0.0114309 Up GO:0006836: neurotransmitter transport2 
FF38_06525 11.7206 8.02734 -0.546048 0.0114309 Up GO:0055114: oxidation-reduction process, GO:0016491: 
oxidoreductase activity2; TauD/TfdA-like domain2 
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Table 8 Continued Summary Table of Cuffdiff Output with Adjusted TopHat Parameters (AB4 vs C4) 
Gene V1 (AB4) V2 (C4) Change1 Q value EL Gene Description 
FF38_06989 50.0383 30.8677 -0.696933 0.0199308 Up Protein coding3 
FF38_07255 43.5559 30.3178 -0.522703 0.0253467 Up Titin, GO:0005515; protein binding, Ig-like domains are 
involved in a variety of functions, including cell-cell 
recognition, cell-surface receptors, muscle structure and the 
immune system2, SH3 domain, Fibronectin type III, N3 exhibits 
functional as well as structural modularity2. Sites of interaction 
with other molecules have been mapped to short stretch of 
amino acids such as the Arg-Gly-Asp (RGD) sequence found in 
various FN3 domains2. The RGD sequences are involved in 
interactions with integrin2. Small peptides containing the RGD 
sequence can modulate a variety of cell adhesion invents 
associated with thrombosis, inflammation, and tumor 
metastasis2. These properties have led to the investigation of 
RGD peptides and RGD peptide analogs as potential therapeutic 
agents2 
FF38_07308 14.2416 7.65268 -0.896074 0.031092 Up GO:0003676; nucleic acid binding, GO:0008270; zinc ion 
binding, GO:0046872; metal ion binding, Zinc finger C2H2-
type/integrase DNA-binding domain2 
FF38_07373 7.29176 4.20396 -0.794518 0.0199308 Up GO:0055114; oxidation-reduction process, putative cytochrome 
P450 6g2 2 
FF38_08124 44.853 28.4741 -0.655552 0.0114309 Up GO:0005576: extracellular region; transferrin like domain; 
Transferrins are a family of eukaryotic iron-binding 
glycoproteins that share the common function of controlling the 
level of free iron in biological fluids2 
FF38_08822 4.4567 1.37675 -1.69471 0.0114309 Up Dmel/edin: defense response to gram negative bacterium4 
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Table 8 Continued Summary Table of Cuffdiff Output with Adjusted TopHat Parameters (AB4 vs C4) 
Gene V1 (AB4) V2 (C4) Change1 Q value EL Gene Description 
FF38_09276 3.55035 1.21834 -1.54305 0.0114309 Up GO:0005549: odorant binding protein2 
FF38_10256 1.1468 0.722912 -0.665719 0.0431833 Up Protein coding3 
FF38_10586 1.0609 0.455742 -1.219 0.0114309 Up GO:0035556: Intracellular signal transduction, GO:0046872: 
metal ion binding, GO:0005622: Intracellular; Protein kinase C-
like, phorbol ester/diacylglycerol-binding domain2 
FF38_11848 23.7023 13.1249 -0.852727 0.0253467 Up Protein coding3 
FF38_12829 4.29603 2.07703 -1.04848 0.0114309 Up GO:0008152: metabolic process, GO:0003824: catalytic activity 
[Source:Ensembl] GO:008152; metabolic process; catalytic 
activity; AMP-dependent synthetase/ligase2 
FF38_13318 3.52794 2.34059 -0.591951 0.0114309 Up Broad-complex core protein isoforms 1/2/3/4/5 3, 
BTB/POZ_dom2 
FF38_14361 4.29547 2.37229 -0.856537 0.0114309 Up GO:0006355: DNA-binding protein D-ETS-62, GO:0003700: 
transcription factor activity, sequence-specific DNA binding2 
FF38_14544 2.57945 1.72996 -0.576326 0.0114309 Up GO:0005515: protein binding. Immunoglobulin-like domain2 
FF38_00744 19.1241 27.2191 0.509227 0.0114309 Down GO:0008061: chitin binding, GO:0005576: extracellular region, 
GO:0006030: chitin metabolic process2 
FF38_01660 245.345 370.152 0.59331 0.0114309 Down GYR motif: Its function is unknown; however, the presence of 
completely conserved tyrosine residues may suggest it could be 
a substrate for tyrosine kinases2 
FF38_01932 9.94015 14.5867 0.553315 0.0114309 Down GO:0042302; structural constituent of cuticle2 
FF38_02709 5.33025 16.5788 1.63707 0.0114309 Down Protein coding3 
FF38_04030 0.887258 1.60498 0.855129 0.0114309 Down GO:0004553; hydrolase activity, hydrolyzing O-glycosyl 
compounds2 
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Table 8 Continued Summary Table of Cuffdiff Output with Adjusted TopHat Parameters (AB4 vs C4) 
Gene V1 (AB4) V2 (C4) Change1 Q value EL Gene Description 
FF38_04791 33.9035 59.9869 0.823212 0.031092 Down Protein coding3 
FF38_05172 29.9994 57.2836 0.933189 0.0114309 Down Protein coding3 
FF38_08169 6.55904 12.26 0.902399 0.0114309 Down Protein coding3 
FF38_09115 1.81841 3.68342 1.01837 0.0431833 Down Protein binding3 
FF38_09596 149.798 238.559 0.671329 0.0253467 Down GO:0003796: lysozyme activity2 
FF38_12201 50.4258 75.5139 0.582581 0.0494645 Down Protein coding3 
FF38_12202 115.576 170.843 0.563837 0.0114309 Down Protein coding3 
FF38_13360 1.51754 2.43457 0.681937 0.0253467 Down GO:0080019:  fatty-acyl-CoA reductase (alcohol-forming) 
activity2 
FF38_14458 1.24446 4.5172 1.85991 0.0114309 Down Protein coding3 
FF38_14459 10.1282 30.0593 1.56943 0.0114309 Down Protein coding3 
FF38_14466 1.59405 3.08638 0.953225 0.0114309 Down Protein coding3 
Abbreviations: AB4 = larvae exposed to A. baumannii for 4 h, C4 = control group larvae not exposed to bacteria for 4 h, EL = expression level, GO = Gene ontology 
GO term, V1 = Value 1, V2 = Value 2. 
Note: Significant values defined as Q ≤ 0.05. 
1 Change presented as log 2 (fold change) function. 
Source: 2 InterPro via EnsemblMetazoa, 3 EnsemblMetazoa, 4 FlyBase, 5 Panther GO Terms 
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Table 9 Continued Summary Table of Cuffdiff Output with Adjusted TopHat Parameters (PA4 vs C4) 
Gene V1 (PA1) V2 (C1) Change1 Q value EL Gene Description 
FF38_05988 6.37032 1.04205 -2.61194 0.0213056 Up Dmel\Hsp22: Heat shock protein4; Alpha-crystallin/Heat shock 
protein: Alpha-crystallin has chaperone-like properties including 
the ability to prevent the precipitation of denatured proteins and 
to increase cellular tolerance to stress2 
FF38_04236 0.84037 0.241859 -1.79686 0.0213056 Up GO:0006508, proteolysis, Cathepsin L2 
FF38_08822 3.64648 1.32953 -1.45559 0.0213056 Up Dmel/edin: defense response to gram negative bacterium4 
FF38_09514 9.28661 3.78323 -1.29553 0.0213056 Up GO:0005515: Kazal domain, serine proteinase inhibitors2 
FF38_01452 100.507 46.5364 -1.11087 0.0213056 Up GO:0008745: N-acetylmuramoyl-L-alanine amidase 
activity,Proteins containing this domain include zinc amidases 
that have N-acetylmuramoyl-L-alanine amidase activity 
EC:3.5.1.28. This enzyme domain cleaves the amide bond 
between N-acetylmuramoyl and L-amino acids in bacterial cell 
walls (preferentially: D-lactyl-L-Ala), GO:0008270: zinc ion 
binding, Peptidoglycan-recognition protein SB1 2 
FF38_10026 1.83936 0.936239 -0.974259 0.0213056 Up GO:0016021; transferase activity, transferring acyl groups other 
than amino-acyl groups2 
FF38_04326 5.74375 3.14782 -0.867639 0.0365238 Up Dmel/pirk: Poor Imd response upon knock-in is a negative 
regulator of the Immune Deficiency (Imd) pathway, acting at the 
level of PGRP-LC. Being regulated by the Imd pathway itself, it 
establishes a negative feedback loop adjusting Imd pathway 
activity to the severity of infection4 
FF38_08298 1.38783 0.819951 -0.759221 0.0213056 Up Dmel\CG8492: protein coding4; Glycoside hydrolase family 22, 
Lysozome like domain2 
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Table 9 Continued Summary Table of Cuffdiff Output with Adjusted TopHat Parameters (PA4 vs C4) 
Gene V1 (PA1) V2 (C1) Change1 Q value EL Gene Description 
FF38_07809 29.3975 17.7661 -0.726568 0.0213056 Up Dmel\Lst Limostatin: Limostatin (Lst) is a peptide hormone 
produced by endocrine corpora cardiaca cells during starvation. 
Lst suppresses insulin production and secretion from insulin-
producing cells by signaling through the G-protein coupled 
receptor PK1-R4 
FF38_05096 1349.58 876.674 -0.622398 0.0213056 Up GO:0042302: structural constituent of cuticle2 
FF38_06525 11.9178 7.78031 -0.61522 0.0365238 Up GO:0055114: oxidation-reduction process, GO:0016491: 
oxidoreductase activity, TauD/TfdA-like domain2 
FF38_01660 234.51 358.503 0.612334 0.0213056 Down GYR motif: Its function is unknown, however the presence of 
completely conserved tyrosine residues may suggest it could be a 
substrate for tyrosine kinases2 
FF38_08047 2.05813 3.50193 0.766816 0.0365238 Down GO:0004222: metalloendopeptidase activity involved in the 
catalysis of the hydrolysis of internal, alpha-peptide bonds in a 
polypeptide chain2; GO:0008270: zinc ion binding defined as 
interacting selectively and non-covalently with zinc (Zn) ions2 
FF38_06814 2.29002 4.18812 0.87094 0.0213056 Down GO:0004252: serine-type endopeptidase activity2 
FF38_02709 6.96294 16.1045 1.2097 0.0213056 Down Protein coding3 
FF38_14466 1.04929 2.99551 1.51339 0.0213056 Down Protein coding3 
FF38_02631 10.8862 40.0823 1.88047 0.0213056 Down Protein coding3 
FF38_02624 53.8452 208.54 1.95343 0.0213056 Down Protein coding3 
FF38_14458 0.834344 4.38123 2.39262 0.0213056 Down Protein coding3 
FF38_14459 2.68447 29.1856 3.44255 0.0213056 Down Protein coding3 
FF38_00716 0 11.6449 inf 0.0213056 Down Protein coding3 
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Table 9 Continued Summary Table of Cuffdiff Output with Adjusted TopHat Parameters (PA4 vs C4) 
Gene V1 (PA1) V2 (C1) Change1 Q value EL Gene Description 
Abbreviations: PA4 = larvae exposed to P. aeruginosa for 4 h, C4 = control group larvae not exposed to bacteria for 4 h, EL = expression level, GO = Gene ontology 
GO term, V1 = Value 1, V2 = Value 2. 
Note: Significant values defined as Q ≤ 0.05. 
1 Change presented as log 2 (fold change) function. 
Source: 2 InterPro via EnsemblMetazoa, 3 EnsemblMetazoa, 4 FlyBase. 
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Pairwise comparisons of expression levels for all genes from Cuffdiff output are 
presented in Fig. 13 (AB4 vs C4) as well as in Fig. 14 (PA4 vs C4). 
Fig. 13: Scatterplot of pairwise gene expression levels between AB4 and C4 with log10 transformed 
FPKM values. Genes that are differentially expressed at a significant level are colored pink. A data point 
above y=x represents a gene that is expressed at higher level in AB4 than in C4. 
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Fig. 14: Scatterplot of pairwise gene expression levels between PA4 and C4 with log10 transformed 
FPKM values. Genes that are differentially expressed at a significant level are highlighted and labeled. A 
data point above y=x represents a gene that is expressed at higher level in PA4 than in C4. 
 
Seventeen down-regulated differentially expressed genes were common to more 
than one analysis set; the Venn diagram in Fig. 15 presents the down-regulated 
significant differentially expressed genes as they appear in each Cuffdiff analysis 
performed with adjusted TopHat parameters. Eleven down-regulated genes are present in 
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both the AB1 vs C1 and PA1 vs C1 data sets. Genes FF38_01660 (possible substrate for 
tyrosine kinase), FF38_02709 (uncharacterized protein), and FF38_14466 
(uncharacterized protein) were down-regulated in both AB4 vs C4 and PA4 vs C4. 
Genes FF38_14458 (uncharacterized protein) and FF38_14459 (uncharacterized protein) 
were found to be down-regulated in AB1 vs C1, AB4 vs C4, and PA4 vs C4. Gene 
FF38_04030 (hydrolase activity, hydrolyzing O-glycosyl compounds) was down-
regulated in AB4 vs C4 and PA1 vs C1. No down-regulated genes were represented in 
all four of the analysis sets.
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Fig. 15: Four-way Venn diagram displaying overlapping counts of significant differentially expressed 
genes that are down-regulated. 
 
The up-regulated genes displaying significant differential expression from all 
Cuffdiff analysis sets are presented in the Venn diagram in Fig. 16. Gene FF38_01916 
(structural constituent of chitin based cuticle) was found to be up-regulated in both AB1 
vs C1 and PA1 vs C1. Gene FF38_09276 (odorant binding protein) was up-regulated in 
both AB1 vs C1 and AB4 vs C4. Genes FF38_01452 (peptidoglycan catabolic process), 
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FF38_04236 (proteolysis), FF38_05096 (structural constituent of cuticle), and 
FF38_06525 (oxido-reductase activity) were up-regulated in AB4 vs C4 and PA4 vs C4. 
Genes FF38_08822 (Dmel/edin: defense response to gram negative bacterium) and 
FF38_04326 (a negative regulator of the Immune Deficiency (Imd) pathway) were up-
regulated in AB1 vs C1, AB4 vs C4, and PA4 vs C4. No up-regulated genes were 
represented in all four of the analysis sets. Expression levels for gene FF38_01452, 
which is also up-regulated in AB4 and PA4 with default TopHat parameters, are 
displayed in Fig. 17. 
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Fig. 16: Four-way Venn diagram displaying overlapping counts of significant differentially expressed 
genes that are up-regulated. 
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Fig. 17: Barplot displaying expression level fpkm values for gene FF38_01452 (AB4 vs C4). Gene 
FF38_01452 is associated with a peptidoglycan catabolic process (the chemical reactions and pathways 
resulting in the breakdown of peptidoglycans, any of a class of glycoconjugates found in bacterial cell 
walls). FF38_01452 is also up-regulated in PA4 vs C4. 
 
 The Panther statistical over-representation test identified up-regulated biological 
processes that were over-represented in the AB1 vs C1 and the AB4 vs C4 data sets. 
Four up-regulated genes from the AB1 vs C1 data set had homologous genes in D. 
melanogaster. Three of the four D. melanogaster genes mapped to a biological process 
described as a response to bacterium. The three genes included FF38_09383, 
FF38_08822, and FF38_04326. There was a 50.06-fold enrichment (P value = 0.0362) 
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compared to the expected number of genes from this category. Twenty-four up- 
regulated genes from the AB4 vs C4 data set had homologous genes in D. melanogaster. 
Six of the D. melanogaster genes mapped to biological processes described as response 
to other organism, response to external biotic stimulus, and a response to biotic stimulus. 
The six genes included FF38_00375, FF38_08822, FF38_01073, FF38_04326, and 
FF38_08124. There was a 11.65-fold enrichment (P value = 0.0256) compared to the 
expected number of genes from this category. Genes from the AB4 vs C4 data set that 
were up-regulated and could be attributed to a known gene in D. melanogaster and 
mapped to a Panther GO-slim Biological process are included in the pie chart in Fig. 18. 
Up-regulated genes from the AB4 vs C4 data set that could be mapped to a Panther GO-
slim molecular function are displayed in Fig. 19. Eight of the 14 categorized genes from 
the AB4 vs C4 data set mapped to the catalytic activity category.
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Fig. 18: Panther GO-Slim Biological Process pie chart displaying biological process categories for up-
regulated genes from the AB4 vs C4 dataset. Gene ontology analysis was performed only for genes that 
had homologous genes in D. melanogaster that could be mapped to a Panther GO-slim biological process. 
Calculated using software tools from Mi et al. 2016. 
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Fig. 19: Panther GO-slim molecular function bar chart displaying molecular function categories for up-
regulated genes from the AB4 vs C4 dataset. Gene ontology analysis was performed only for genes that 
had homologous genes in D. melanogaster that could be mapped to a Panther GO-slim molecular function. 
Calculated using software tools from Mi et al. 2016. 
 
Sequence Alignment to the L. sericata Reference Genome 
Alignment of one dataset of the RNAseq files to the L. sericata genome using the 
default parameters in TopHat resulted in a concordant pair alignment rate of 48.4%. No 
further analysis was performed due to the lack of a compatible annotation file at the time 
of analysis. A summary of the alignment information from the TopHat output is 
provided in Fig. 20.  
 67 
 
Fig. 20: TopHat output summary of RNAseq alignment to the L. sericata reference genome with default 
parameters. 
 
Discussion 
 
Genes were identified that showed a significant increase or decrease in transcript 
abundance potentially due to bacterial exposure (Tables 2-9). Identified genes include 
those associated with antimicrobial activity, immune response, proteolytic activity, 
catalytic activity, response to gram negative bacteria, and uncharacterized proteins. The 
ability to assign gene functions or categorize genes that are differentially expressed 
enables relevant information to be presented. For the genes that were identified and 
characterized, some were associated with immune responses or antimicrobial activity. 
Control of Gram-negative bacteria is important in maggot therapy due to the prevalence 
and severity of wounds infected with antimicrobial resistant Gram-negative bacteria.
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In the AB4 vs C4 dataset, six genes were identified that were associated with an 
over-representation of response to biotic stimulus genes. The predicted functions of 
these genes include: endopeptidase inhibitor activity- Alpha-2-macroglobulin (Finn et al. 
2016), defense response to Gram-negative bacterium in D. melanogaster (Attrill et al. 
2015), interacting selectively and non-covalently with any protein or protein complex 
(Finn et al. 2016), establishing a negative feedback loop adjusting Imd pathway activity 
to the severity of infection in D. melanogaster (Attrill et al. 2015), and transferrins- 
eukaryotic iron-binding glycoproteins that share the common function of controlling the 
level of free iron in biological fluids (Finn et al. 2016). In the AB1 vs C1 dataset, three 
genes were identified that were associated with an over-representation of response to 
bacterium genes. The predicted functions of these genes include: defense response to 
gram negative bacterium in D. melanogaster (Attrill et al. 2015), the antimicrobial 
peptide Attacin-A (Finn et al. 2016), and establishing a negative feedback loop adjusting 
Imd pathway activity to the severity of infection in D. melanogaster (Attrill et al. 2015). 
The duration of bacterial exposure (1 h vs 4 h) may explain why more differentially 
expressed genes were identified in the 4 h data set vs the 1 h dataset. The previously 
mentioned genes contribute to the insect immune response pathway which includes 
recognition, signaling, and the transcription of an effector molecule. Some identified 
genes also play a role in the regulation of these pathways. 
In general, there were more changes in transcript abundance when larvae were 
exposed to bacteria for 4 h vs 1 h. In nutritional studies in Drosophila, transcript ratios 
for some genes were observed to increase in the first hour, accumulate until 7 h, but then 
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relatively few changes were detected after 7 h (Gershman et al. 2007). For L. sericata 
larvae, bacterial exposure longer than 4 h may lead to the identification of more 
differentially expressed genes or allow for a greater increase in transcript abundance for 
some immunity related genes. When Medical Maggots™ are used for medicinal 
purposes in wound environments, each application of maggots is administered for up to 
48 hours (Monarch Labs 2015); RNA-Seq experiments designed with longer bacterial 
exposure times could correspond more with therapeutic maggot use. 
 The majority of the differentially expressed genes are unique to a specific time 
point or bacterial exposure, but some genes are differentially expressed in more than one 
time point or bacterial exposure (Figs. 5, 6, 14, and 15). For example, gene FF38_01452 
shows increased transcript abundance with exposure to A. baumannii and P. aeruginosa 
for 4 h. This gene is involved with innate immunity by degrading bacterial 
peptidoglycans (The UniProt Consortium 2014), a constituent of bacterial cell walls, and 
so its increased expression level with exposure to different species of bacteria is not 
surprising. 
Significant expression level differences in transcripts due to bacterial exposure 
were typically low to moderate in terms of log2 fold change differences. Increased 
duration of bacterial exposure or increased bacterial load may result in a greater increase 
in transcript abundance. Although, co-expression of antimicrobial peptides has been 
observed in Diptera (De Gregorio et al. 2001) and synergism between these peptides 
would support lower quantities of individual peptides being produced so that a 
combinatorial effect is more practical and beneficial (Cassone and Otvos Jr 2010, Rolff 
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and Schmid-Hempel 2016). Specifically, a combination of antimicrobial peptides from 
L. sericata displayed synergistic activity against microbes (Pöppel et al. 2015). 
Synergistic or combinatorial effects of gene products might explain the observed levels 
of transcript abundance for relevant genes. 
In summary, genes involved with immune response pathways and transcription of 
antimicrobial peptides are differentially expressed upon larval exposure to Gram-negative 
bacteria. This study provides insight into the signaling pathways and induced immune 
responses in L. sericata. Further studies could further identify specific proteins or 
molecules that are produced in response to specific bacteria. In addition, larvae could be 
genetically engineered or enhanced to be successful against specific bacteria in a wound 
environment. Information from this study could also provide a framework or supplemental 
data for studying a similar immune response to pathogens in non-lab strains of L. sericata 
or perhaps in other insects. 
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CHAPTER III  
FUTURE STUDIES AND LIMITATIONS 
 
Antimicrobial peptides that are synthesized during exposure to different species 
of bacteria could be used as a broad-spectrum therapeutic agent. Further study of the 
identified transcripts that are unique to a specific type of bacterial exposure could 
potentially identify gene products that are specific (narrow-spectrum) to a particular 
bacterial species. Larval exposure to more types of bacteria, including Gram-positive 
species, could help identify more gene products that are specific to different types of 
bacteria. 
Analyzing the RNA-Seq data with a high quality and well annotated reference 
genome could improve the sequencing data, and identify, as well as characterize, more 
genes that are differentially expressed. Future enhancements to software programs or the 
use of different software programs could potentially enhance the analysis of the RNA-
Seq data along expanding the scope of the analysis.  
Due to the complex nature of protein synthesis, identifying differentially 
expressed genes by quantifying increases in transcript abundance does not necessarily 
mean that those gene products or peptides are being synthesized, secreted or utilized. 
Also, some identified genes could be incorrectly characterized or misidentified due to 
technological limitations in the quality of the annotation data. A transcriptomics as well 
as a proteomics approach would provide a more thorough evaluation of the mechanisms 
in play. Additional studies could include matching mass spectrometry analysis of the 
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protein content in larval tissues to identified RNA-Seq data. Also, the antibacterial 
activity of select peptides can be evaluated by purchasing synthesized peptides and 
determining the minimum inhibitory concentration (MIC) with exposure to different 
bacterial species. 
 Gene products could also be evaluated for the potential to disrupt biofilm 
formation. Different developmental stages of the larvae could also be incorporated to 
compare the larval immune response across different developmental stages. 
Additionally, the larvae could be dissected prior to RNA extraction so that tissue specific 
RNA could be isolated instead of the whole larval extractions. Tissue specific analysis 
may yield more functionally relevant information and data has shown that antimicrobial 
peptides are expressed at higher levels in the fat body as compared to whole larvae 
(Pöppel et al. 2015). In another study, lucifensin expression was only increased in the fat 
body with certain infectious environments (Valachova et al. 2013). Genes associated 
with antimicrobial activity could be expressed at high levels regardless of the larvae 
being in an infectious environment, but this study was not designed to identify gene 
expression in this manner. Further data analysis could explore expression levels and 
sequence information of antimicrobial peptides in the larvae that is not due to bacterial 
exposure. 
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